Bullard v. Drug Policy Alliance

CourtDistrict Court, S.D. New York
DecidedDecember 30, 2019
Docket1:18-cv-08081
StatusUnknown

This text of Bullard v. Drug Policy Alliance (Bullard v. Drug Policy Alliance) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bullard v. Drug Policy Alliance, (S.D.N.Y. 2019).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK CAROL A. BULLARD, also known as ASHA BANDELE, Plaintiff, -v.- 18 Civ. 8081 (KPF) DRUG POLICY ALLIANCE, MARIA McFARLAND, and JAMES FERGUSON, OPINION AND ORDER Defendants. DRUG POLICY ALLIANCE, Counter-Claimant, -v.- CAROL A. BULLARD, also known as ASHA BANDELE, Counter-Defendant. KATHERINE POLK FAILLA, District Judge: Plaintiff Carol Bullard, also known as Asha Bandele (“Bandele”), brought the instant action against her former employer, the Drug Policy Alliance (“DPA”), and several of its employees, alleging claims of race and sex discrimination in violation of federal, state, and local law. DPA then filed counterclaims against Bandele for breach of fiduciary duty and fraud, alleging that she misappropriated DPA’s funds by arranging for DPA to enter into a series of contracts with a personal friend, Kirsten West Savali (“West Savali”), to provide press coverage about DPA. DPA claims that Bandele actively concealed the true nature of the contracts from DPA, and that DPA would not have entered into the transactions if it had known that Bandele was paying West Savali personally, rather than through West Savali’s employer. Bandele has moved to dismiss DPA’s counterclaims for failure to state a claim, and

alternatively asks the Court to decline to exercise supplemental jurisdiction over these state-law counterclaims. For the reasons explained below, Bandele’s motion to dismiss is denied in full. BACKGROUND1 A. Factual Background DPA is a non-profit organization and a leading advocate for drug policy reform. (Countercl. ¶ 148). Bandele became affiliated with DPA in 2006 and joined as an employee on January 1, 2009. (Id. at ¶ 20; Answer ¶ 2). As of 2015, Bandele held the title of Senior Director of Grants, Partnerships, and Special Projects. (Countercl. ¶ 166; Answer ¶ 2). As a Senior Director, Bandele

reported to Widney Brown, who became the Managing Director for Policy in October 2017. (Countercl. ¶¶ 167, 173). In turn, Brown reported to DPA’s Executive Director, Maria McFarland. (Id. at ¶¶ 167, 170). DPA operates on donations and, consequently, structures its budget to focus on expenses that aid its mission. (Countercl. ¶ 234). DPA typically receives journalistic coverage for free; it does not pay news organizations or

1 The facts contained in this Opinion are drawn principally from DPA’s Answer and Counterclaims (“Countercl.”). (Dkt. #23). References in this Opinion to “Defendant” pertain to DPA, the only defendant to bring counterclaims in this action. For ease of reference, the Court refers to the parties’ briefing as follows: Plaintiff Bandele’s opening brief as “Pl. Br.” (Dkt. #33); Defendant DPA’s opposition brief as “Def. Opp.” (Dkt. #35); and Plaintiff Bandele’s reply brief as “Pl. Reply” (Dkt. #37). journalists on staff at other news organizations directly for coverage of DPA, except in the form of “sponsored content” that is clearly labeled as such. (Id. at ¶¶ 223-24). DPA’s viability as a successful non-profit organization depends on

its reputation of credibility and fair-dealing. (Id. at ¶ 238). In 2016, DPA engaged in a journalistic partnership with The Root, an online magazine with a focus on African-American news and culture. (Id. at ¶¶ 225, 151). The partnership consisted only of working together on stories and cross-publishing material. (Id. at ¶ 225). It did not include any exchange of funds. (Id.). In March 2017, DPA received a significant grant from a funder. (Countercl. ¶ 174). Bandele was tasked with supervising much of the work under this grant. (Id.). Between 2016 and 2018, Bandele entered into four

contracts on behalf of DPA with West Savali, a journalist for The Root and a personal friend. (Id. at ¶¶ 151, 152, 154, 175). Each of the contracts indicated that West Savali would be paid for content that supported DPA’s mission and would be published in The Root. (Id. at ¶ 176).2 Of potential note, the contracts were each addressed to West Savali’s home address and personal email account. (Id. at ¶ 178). All of the payments for the contract were made to West Savali personally, and not to The Root or any other journalistic entity. (Id. at ¶ 179).

2 Several of the contracts provided that West Savali would engage in live Facebook chats coordinated by Bandele and The Root. (Countercl. ¶ 177). Additionally, several of the contracts provided that West Savali’s content would be cross-posted to DPA’s website after appearing in The Root. (Id.). Specifically, on December 1, 2016, West Savali entered into a contract with DPA according to which West Savali would be paid $5,000 to report four articles designed to engage African American and Southern communities about

the drug war to be featured in The Root or other publications. (Countercl. ¶ 181). On April 1, 2017, West Savali entered into another contract with DPA according to which West Savali would be paid $15,000 for seven articles addressing the impact of the drug war on the American South to be featured in The Root. (Id. at ¶ 182). On November 3, 2017, West Savali entered into a third contract with DPA according to which West Savali would receive $15,000 to write five articles about the drug war in connection with Black History Month in The Root. (Id. at ¶ 183). And on March 14, 2018, West Savali

entered into a fourth contract with DPA according to which West Savali would be paid $10,000 for coverage of a DPA delegation to Portugal for The Root. (Id. at ¶ 184). As a director-level employee, Bandele was responsible for the content of the contracts. (Countercl. ¶ 192). Bandele did not obtain substantive review of the contracts from either her supervising Managing Director or the Executive Director. (Id. at ¶ 194). Rather, she actively concealed the contracts from her direct supervisors because she knew that her supervisors would not approve

them. (Id. at ¶ 195). Bandele endeavored to comply with the letter, but not the spirit, of DPA policy, which requires that all contracts be signed by either the Executive Director or the Managing Director of Finance, Ryan Chavez. (Countercl. ¶ 191). Bandele presented the contracts to Chavez, who is an accountant, for his signature. (Id. at ¶ 193). While Chavez reviewed and approved the procedural and accounting aspects of the contracts, he was not qualified (as Bandele well

knew) to challenge the substance of the contracts. (Id. at ¶¶ 193, 195). In order to obtain his signature, Bandele led Chavez to believe that the contracts were negotiated in the normal course and would have been approved by Bandele’s supervisors if they had been shown to those individuals. (Countercl. ¶ 196). She repeatedly told Chavez that the contracts needed to be signed with urgency, so as not to permit Chavez time to consult with other senior DPA management. (Id. at ¶ 197). For example, on March 14, 2018, at 4:00 p.m., Bandele emailed Chavez with high importance, with the subject-line

“RYAN — Can you sign this pleeeeease???????,” attaching the contract with West Savali for the Portugal trip. (Id. at ¶ 200). Bandele stated that she “neglected to move Kirsten’s contract for Portugal. Would you mind signing this so that we can provide her funds to her via PayPal tomorrow? Thank you so much!!!!!!!!!” (Id.). Chavez responded to Bandele indicating that he was out of the office and suggested that Bandele have the contract reviewed and signed by McFarland to expedite the matter. (Id. at ¶ 204). Despite the professed urgency, Bandele declined to present the contract to McFarland and told

Chavez she preferred to wait for him to sign the contract when he returned to the office. (Id. at ¶ 205). On March 14, 2018, DPA’s Policy Team revised its internal procedures to require all contracts to be reviewed substantively by a supervising Managing Director or the Executive Director. (Countercl. ¶ 199).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Caterpillar Inc. v. Williams
482 U.S. 386 (Supreme Court, 1987)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Johnson v. Nextel Communications, Inc.
660 F.3d 131 (Second Circuit, 2011)
Gordon & Co. v. Arthur H. Ross
84 F.3d 542 (Second Circuit, 1996)
Metro Foundation Contractors, Inc. v. Arch Insurance
498 F. App'x 98 (Second Circuit, 2012)
Lama Holding Co. v. Smith Barney Inc.
668 N.E.2d 1370 (New York Court of Appeals, 1996)
Slue v. New York University Medical Center
409 F. Supp. 2d 349 (S.D. New York, 2006)
In Re Livent, Inc. Noteholders Securities Litig.
151 F. Supp. 2d 371 (S.D. New York, 2001)
Twenty First Century L.P.I v. LaBianca
19 F. Supp. 2d 35 (E.D. New York, 1998)
Lamdin v. Broadway Surface Advertising Corp.
5 N.E.2d 66 (New York Court of Appeals, 1936)
Birnbaum v. Birnbaum
539 N.E.2d 574 (New York Court of Appeals, 1989)
Vermeer Owners, Inc. v. Guterman
585 N.E.2d 377 (New York Court of Appeals, 1991)
Barrett v. Freifeld
64 A.D.3d 736 (Appellate Division of the Supreme Court of New York, 2009)
CBS Corp. v. Dumsday
268 A.D.2d 350 (Appellate Division of the Supreme Court of New York, 2000)
A.V.E.L.A., INC. v. Estate of Marilyn Monroe, LLC
131 F. Supp. 3d 196 (S.D. New York, 2015)
Nielsen v. AECOM Technology Corp.
762 F.3d 214 (Second Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Bullard v. Drug Policy Alliance, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bullard-v-drug-policy-alliance-nysd-2019.